SJ1008030 (formic)

CAT: 0804-HY-147330B-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-147330B-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
SJ1008030 (compound 8) formic is a JAK2 PROTAC which selectively degrades JAK2. SJ1008030 formic inhibits MHH–CALL-4 cell growth with an IC50 of 5.4 nM. SJ1008030 formic can be used for the research of leukemia[1].
UNSPSC
12352005
Target
JAK; PROTACs
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; PROTAC; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sj1008030-formic.html
Purity
97.66
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=S(CC)(N1CC(N2C=C(C=N2)C3=C4C=CNC4=NC(NC5=CC=C(C=C5)C(NCCN6CCN(CC6)C7=CC=C8C(N(C9CCC(NC9=O)=O)C(C8=C7)=O)=O)=O)=N3)(CC#N)C1)=O.OC=O
Molecular Formula
C43H45N13O9S
Molecular Weight
919.96
References & Citations
[1]Chang Y, et al. Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia. Blood. 2021 Dec 9;138 (23) :2313-2326.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JAK2

Related Products

CatalogName
HY-147330SJ1008030
HY-147330A-01SJ1008030 (TFA)
HY-161242A-01CBI1 (formic)
HY-16138A-01Ivaltinostat (formic)
HY-122653A-01CCT367766 (formic)
HY-134813AMRTX1133 (formic)
HY-11038D-01Zelavespib (formic)
HY-101489A-01GZD856 (formic)
HY-162959A-01BWC0977 (formic)
HY-150254A-01SLB1122168 (formic)

Alternative Products

CatalogName
MBS5819615SJ1008030 formic
A23978-10SJ1008030 formic 10mg
A23978-1SJ1008030 formic 1mg
A23978-5SJ1008030 formic 5mg
A23978-50SJ1008030 formic 50mg
MF-0154833-01SJ1008030
OR1102042-01SJ1008030 formate
MBS5819614SJ1008030 TFA
A24097-10SJ1008030 TFA 10mg
A24097-1SJ1008030 TFA 1mg

Popular Products